Provided by Tiger Trade Technology Pte. Ltd.

RxSIGHT, INC.

7.66
+0.28003.79%
Volume:24.11K
Turnover:183.00K
Market Cap:314.95M
PE:-8.06
High:7.66
Open:7.60
Low:7.54
Close:7.38
52wk High:16.74
52wk Low:5.90
Shares:41.12M
Float Shares:32.44M
Volume Ratio:1.42
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9500
EPS(LYR):-0.9533
ROE:-13.99%
ROA:-9.56%
PB:1.14
PE(LYR):-8.04

Loading ...

RxSight highlights ASCRS data showing 91.2% LAL accuracy within 0.50 diopters

Reuters
·
Apr 09

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

GlobeNewswire
·
Apr 09

RxSight to join Needham Virtual Healthcare Conference fireside chat

Reuters
·
Apr 03

RxSight amends CFO appointment filing to disclose USD 169,348 sign-on bonus

Reuters
·
Mar 20

RxSight Earnings Call: Strong Core, Cautious Outlook

TIPRANKS
·
Mar 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: Silence Therapeutics (SLN), RxSight (RXST) and Compass Therapeutics (CMPX)

TIPRANKS
·
Mar 06

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), BioLife Solutions (BLFS) and RxSight (RXST)

TIPRANKS
·
Feb 27

UBS Adjusts Price Target on RxSight to $9 From $8, Maintains Neutral Rating

MT Newswires Live
·
Feb 26

RxSight price target raised to $9 from $8 at UBS

TIPRANKS
·
Feb 26

RxSight Price Target Maintained With a $13.00/Share by Needham

Dow Jones
·
Feb 26

Wells Fargo Remains a Hold on RxSight (RXST)

TIPRANKS
·
Feb 26

Rxsight Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 26

RxSight Q4 revenue falls 19% on lower LDD sales

Reuters
·
Feb 26

RxSight Q4 Adj. EPS $(0.03) Beats $(0.33) Estimate, Sales $32.607M Beat $30.117M Estimate

Benzinga
·
Feb 26

BRIEF-Rxsight Q4 Gross Profit USD 25.3 Million

Reuters
·
Feb 26

Rxsight Outlook FY Revenue USD 120-135 Million

THOMSON REUTERS
·
Feb 26

Press Release: RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance

Dow Jones
·
Feb 26

Rxsight Inc expected to post a loss of 33 cents a share - Earnings Preview

Reuters
·
Feb 24

Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Senseonics Holdings (SENS) and Novo Nordisk (NVO)

TIPRANKS
·
Feb 21

RxSight Inc. Files Initial Statement of Beneficial Ownership for Chief Financial Officer Mark Wilterding

Reuters
·
Jan 31